DMC Biotechnologies

company

About

DMC Biotechnologies produces bio-based chemicals using fermentation.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$39M
Industries
Biotechnology,Chemical,Commercial,Food and Beverage,Manufacturing
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

DMC Biotechnologies produces bio-based chemicals using fermentation. The company's technology makes products using lower energy and resources, with applications that contribute to a sustainable economy. DMC Biotechnologies, Inc. was founded in 2014 by Matt Lipscomb and Mike Lynch and is based in Boulder, Colorado, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$51.88M
DMC Biotechnologies has raised a total of $51.88M in funding over 2 rounds. Their latest funding was raised on Dec 2, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 2, 2021 Series B $39M 1 Detail
Dec 18, 2019 Series A $11.30M 1 Detail
Aug 30, 2017 Grant $1.33M 1 National Science Foundation Detail
Dec 18, 2015 Grant $241.25K 1 National Science Foundation Detail

Investments

Number of Investments
Number of Lead Investments
4
1
DMC Biotechnologies has made 4 investments. Their most recent investment was on Apr 28, 2020, when Aesthetic raised $3.10M.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 28, 2020 Aesthetic
Seed $3.10M Blockchain
May 1, 2019 Golden
Seed $5M Artificial Intelligence
Jan 1, 2019 Nearside
Seed $5M Financial Services
Aug 19, 2014 ClearTax
Pre-seed Accounting Yes

Investors

Number of Lead Investors
Number of Investors
2
2
DMC Biotechnologies is funded by 2 investors. National Science Foundation and SCG Holdings are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
SCG Holdings Series B